NCT06835868 Neuro-Pain Provides a Dynamic and Interactive Register for the Invasvive Neuromodulatory Therapies for Different Chronic Pain Syndromes. Patients Living in Belgium and Suffering From Persistent Spinal Pain Syndromes Type 2 as Well as Suffering From Complex Regional Pain Syndromes Are Included.
| NCT ID | NCT06835868 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Antwerp |
| Condition | Chronic Pain Syndromes |
| Study Type | OBSERVATIONAL |
| Enrollment | 7,000 participants |
| Start Date | 2018-02-14 |
| Primary Completion | 2030-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 7,000 participants in total. It began in 2018-02-14 with a primary completion date of 2030-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patients suffereing from chronic pain due to persistent spinal pain syndromes or complex regional pain syndromes and living in Belgium will be included in this register once they are being considered for a treatment with invasive neuromodulation (either spinal cord stimulation either dorsal root ganglion stimulation). The screening process, the multidisciplinary evaluation, the trial therapy and the long-terl follow-up will be monitored through this register.
Eligibility Criteria
Inclusion Criteria: * chronic pain syndromes Exclusion Criteria: * acute pain syndromes
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06835868 clinical trial?
This trial is open to participants of all sexes, studying Chronic Pain Syndromes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06835868 currently recruiting?
Yes, NCT06835868 is actively recruiting participants. Contact the research team at guy.hans@uza.be for enrollment information.
Where is the NCT06835868 trial being conducted?
This trial is being conducted at Edegem, Belgium.
Who is sponsoring the NCT06835868 clinical trial?
NCT06835868 is sponsored by University Hospital, Antwerp. The trial plans to enroll 7,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.